Iopamiro 300

Iopamidol, the active ingredient in Iopamiro 300, is a nonionic iodinated contrast agent presented as a 300 mg I/mL solution for injection for intravenous use. It provides radiographic contrast enhancement during diagnostic imaging procedures, helping clinicians visualize blood vessels and organ structures in patients undergoing examinations such as CT scans or angiography.

GNH USA supplies Iopamiro 300 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic imaging centres and procurement teams worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Iopamiro 300 is used as a radiographic contrast medium to improve visualization of vascular and organ structures during imaging procedures.

- Computed Tomography (CT): Enhances tissue differentiation and vessel delineation during CT scans. - Angiography: Improves visualization of arterial and venous anatomy during angiographic studies. - Urography: Provides contrast for detailed imaging of the urinary tract. - Myelography: Facilitates clear imaging of the spinal canal and nerve roots. - Cardiac catheterization: Enhances contrast of cardiac chambers and coronary arteries during catheter‑based procedures.

Adverse reactions to Iopamiro 300 are generally related to its iodine content and route of administration.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste in the mouth. - Mild nausea or vomiting. - Headache or dizziness. - Transient itching or urticaria. - Injection site discomfort.

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis. - Acute kidney injury or worsening of pre‑existing renal impairment. - Hypotension or cardiovascular collapse. - Seizures or neurological disturbances. - Pulmonary edema or respiratory distress. - Cardiac arrhythmias or cardiac arrest.

Prior to administration, clinicians should assess patient-specific risk factors and follow recommended safety measures.

- Renal function: Evaluate baseline kidney function and consider hydration protocols. - Allergy history: Screen for prior reactions to iodinated contrast or iodine‑containing substances. - Thyroid disease: Use caution in patients with hyperthyroidism or thyroid disorders. - Pregnancy: Avoid unless clearly essential, as fetal safety data are limited. - Hydration: Ensure adequate patient hydration to mitigate nephrotoxicity risk. - Store below 25°C: Keep in the original packaging, protect from moisture and light.

Iopamiro 300 may interact with other agents that affect renal function or iodine load.

Major Interactions (Avoid): - Iodine‑containing medications (e.g., amiodarone) that increase total iodine exposure. - Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs) that can exacerbate renal injury. - Metformin in patients with impaired renal function due to risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers that may mask contrast‑induced hypertension. - Diuretics that influence fluid balance; monitor electrolytes and volume status.